Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderately Impaired Renal Function”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT05342623
What this trial is testing

Evaluate the Safety and Efficacy of Difelikefalin in Advanced Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus

Who this might be right for
Chronic Kidney DiseasesPruritus
Cara Therapeutics, Inc. 286
Large-scale testing (Phase 3)Study completedNCT00501046
What this trial is testing

AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease Including Assessment of Quality of Life (EPPIC-2)

Who this might be right for
Chronic Kidney Disease
Tanabe Pharma Corporation 1,015
Not applicableStudy completedNCT07370662
What this trial is testing

Effect of Resistance Exercises and Relaxation Therapy on Physical Function and Quality Of Life in Patients With Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease (Mild to Moderate)
Rashid Latif Medical College 50
Early research (Phase 1)Study completedNCT03913000
What this trial is testing

Evaluate ID-085 in People With Mild, Moderate, and Severe Kidney Disease

Who this might be right for
Renal Impairment
Idorsia Pharmaceuticals Ltd. 32
Not applicableStudy completedNCT02923063
What this trial is testing

Exercise Study Testing Enhanced Energetics of Mitochondria Video Integrated Delivery of Activity Training in CKD

Who this might be right for
Moderate-severe Chronic Kidney Disease Not Treated With DialysisDiabetic Kidney Disease, HgbA1c Less Than 8.5
University of California, Davis 32
Early research (Phase 1)Study completedNCT03259087
What this trial is testing

Pharmacokinetics (PK) and Safety of a Single Intravenous (IV) Dose of MK-3866 in Participants With Impaired Renal Function and in Healthy Controls (MK-3866-005)

Who this might be right for
Renal Impairment
Merck Sharp & Dohme LLC 42
Early research (Phase 1)Study completedNCT01444872
What this trial is testing

Study to Evaluate TRV120027 on Renal Pharmacodynamics in Patients With Heart Failure and Renal Dysfunction

Who this might be right for
Heart FailureKidney Disease
Trevena Inc. 17
Not applicableStudy completedNCT00893165
What this trial is testing

Does Moderate Physical Activity in Hemodialysis Patients Reduce Inflammation?

Who this might be right for
End-stage Renal DiseaseHemodialysis
Martin-Luther-Universität Halle-Wittenberg 16
Early research (Phase 1)Study completedNCT03814005
What this trial is testing

Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myelomonocytic, ChronicLeukemia, Myeloid, Acute+3 more
Takeda 17
Large-scale testing (Phase 3)Study completedNCT02807987
What this trial is testing

Study of CS-3150 in Combination With ARB or ACE Inhibitor in Hypertensive Patients With Moderate Renal Impairment

Who this might be right for
Hypertension With Moderate Renal Impairment
Daiichi Sankyo Co., Ltd. 58
Early research (Phase 1)Not Yet RecruitingNCT07445906
What this trial is testing

RG002C0106 Injection in Adult Participants With Normal Renal Function and Mild-to-Moderate Renal Impairment

Who this might be right for
Renal ImpairmentsIgA Nephropathy (IgAN)
Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Co., Ltd. 24
Post-approval studies (Phase 4)Study completedNCT01172431
What this trial is testing

Indapamide Versus Hydrochlorothiazide in Elderly Hypertensive Patients With Renal Insufficiency

Who this might be right for
HypertensionRenal Insufficiency
West China Hospital 240
Post-approval studies (Phase 4)Study completedNCT05305495
What this trial is testing

Empagliflozin in Acute Heart Failure

Who this might be right for
Acute Heart FailureChronic Kidney Diseases
McGill University Health Centre/Research Institute of the McGill University Health Centre 25
Not applicableUnknownNCT03108222
What this trial is testing

Phosphorus Absorption in Healthy Adults and in Patients With Moderate Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease Mineral and Bone Disorder
Purdue University 20
Early research (Phase 1)Study completedNCT00999336
What this trial is testing

Determine the Pharmacokinetics, Pharmacodynamics, and Tolerabiltiy of Betrixaban in Patients With Mild, Moderate, and Severe Renal Impairment

Who this might be right for
Renal Impairment
Portola Pharmaceuticals 32
Testing effectiveness (Phase 2)Study completedNCT03617536
What this trial is testing

Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus

Who this might be right for
Chronic Kidney DiseasesPruritus
Cara Therapeutics, Inc. 269
Early research (Phase 1)Study completedNCT05704556
What this trial is testing

Evaluation of the Pharmacokinetics and Safety of VX-548 in Participants With Renal Impairment

Who this might be right for
Pain
Vertex Pharmaceuticals Incorporated 38
Early research (Phase 1)WithdrawnNCT05406219
What this trial is testing

Learn How the Study Treatment BAY2395840 Moves Into, Through and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Moderate Reduced Kidney Function and in Healthy Male and Female Participants With Normal Kidney Function

Who this might be right for
Diabetic Neuropathic PainRenal ImpairmentHealthy Volunteers
Bayer
Large-scale testing (Phase 3)Study completedNCT01020487
What this trial is testing

Safety and Efficacy of Paricalcitol Capsules in Decreasing Serum Parathyroid Hormone Levels in Children Aged 10-16 With Chronic Kidney Disease (CKD)

Who this might be right for
Chronic Kidney Disease Stage 3 and 4
AbbVie (prior sponsor, Abbott) 47
Testing effectiveness (Phase 2)Study completedNCT01407874
What this trial is testing

A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal Insufficiency

Who this might be right for
GoutHyperuricemiaArthritis+2 more
BioCryst Pharmaceuticals 20
Next Page